U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
On Nov. 21, 2025, Pfizer and Astellas Pharma announced that the U.S. Food and Drug Administration (FDA) has…
On Aug. 3, 2009, researchers at Stanford’s School of Medicine announced they had identified the first human bladder…